InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the full record of transactions filed by Grayzel David S., 董事. Officer active across 2 companies, notably Aerovate Therapeutics, Inc.. Aggregated, 3 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €308k. Activity tracked since 9 April 2024. The latest transaction was filed on 9 April 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Grayzel David S.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
11,882 股@ US$28.15100.0% 占其流量Common StockSEC:0001415889-24-010709:0
2,945,453 股Common StockSEC:0001209191-23-048755:0
2,568,165 股Common StockSEC:0001104659-21-089435:0
3 条申报中的 3 条
About Grayzel David S.
Grayzel David S. is a Director at Aerovate Therapeutics, Inc. In this role, he oversees the company's activities and participates in strategic decision-making. David is committed to promoting transparency and ensuring that shareholder interests are considered in all decisions.
